Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (새로운 창 열기)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Source‎: Crit Care Med 2009;37(4):1299-307.

Indexed‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (새로운 창 열기)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (새로운 창 열기)

Ball AM, Winstead PS.

Source‎: Pharmacotherapy 2008;28(11):1383-90.

Indexed‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (새로운 창 열기)

Reducing postburn injury anemia in a Jehovah's Witness patient. (새로운 창 열기)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Source‎: J Burn Care Res 2014;35(4):e258-61.

Indexed‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (새로운 창 열기)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (새로운 창 열기)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Source‎: Clin Ther 2008;30(12):2324-34.

Indexed‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (새로운 창 열기)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (새로운 창 열기)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Source‎: Transplant Proc 2015;47(8):2548-51.

Indexed‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (새로운 창 열기)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (새로운 창 열기)

Charles A, Purtill M, Napolitano LM.

Source‎: Anaesth Intensive Care 2006;34(6):793-6.

Indexed‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (새로운 창 열기)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (새로운 창 열기)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Source‎: Crit Care Med 1999;27(11):2346-50.

Indexed‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (새로운 창 열기)

Erythropoietin for critically ill trauma patients: a missed opportunity? (새로운 창 열기)

Corwin HL, Napolitano LM

Source‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Indexed‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (새로운 창 열기)

Postoperative management of severe acute anemia in a Jehovah's Witness. (새로운 창 열기)

de Araújo Azi LM, Lopes FM, Garcia LV

Source‎: Transfusion 2014;54(4):1153-7.

Indexed‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (새로운 창 열기)

Restrictive transfusion in geriatric trauma patients. (새로운 창 열기)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Source‎: Am Surg 2016;82(1):85-8.

Indexed‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (새로운 창 열기)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (새로운 창 열기)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Source‎: J Trauma 1998;44(2):361-7.

Indexed‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (새로운 창 열기)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (새로운 창 열기)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Source‎: Crit Care 2005;9(5):R508-15.

Indexed‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (새로운 창 열기)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (새로운 창 열기)

Hong T, Shander A, Agarwal S, Castresana M.

Source‎: A A Case Rep 2015;4(10):127-31.

Indexed‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (새로운 창 열기)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (새로운 창 열기)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Source‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Indexed‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (새로운 창 열기)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (새로운 창 열기)

Lindholm J, Palmér K, Frenckner B.

Source‎: Perfusion 2012;27(4):332-4.

Indexed‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (새로운 창 열기)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (새로운 창 열기)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Source‎: Am Surg 2010;76(9):951-6.

Indexed‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (새로운 창 열기)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (새로운 창 열기)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Source‎: Intensive Care Med 2013;39(11):1896-908.

Indexed‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (새로운 창 열기)

Transfusion-free treatment strategies for acute anemia in critical care. (새로운 창 열기)

Morgan CA, Byul Sarah S, Forest CP.

Source‎: JAAPA 2016;29(8):38-44.

Indexed‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (새로운 창 열기)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (새로운 창 열기)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Source‎: J Trauma 2008;65(2):285-97.

Indexed‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (새로운 창 열기)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (새로운 창 열기)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Source‎: J Trauma 2009;67(1):121-4.

Indexed‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (새로운 창 열기)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (새로운 창 열기)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Source‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indexed‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (새로운 창 열기)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (새로운 창 열기)

Posluszny JA Jr, Napolitano LM.

Source‎: Transfusion 2014;54(12):3026-34.

Indexed‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (새로운 창 열기)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (새로운 창 열기)

Price S, Pepper JR, Jaggar SI.

Source‎: Anesth Analg 2005;101(2):325-7.

Indexed‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (새로운 창 열기)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (새로운 창 열기)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Source‎: Am Surg 2015;81(6):e263-5.

Indexed‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (새로운 창 열기)

Erythropoietin response is blunted in critically ill patients. (새로운 창 열기)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Source‎: Intensive Care Med 1997;23(2):159-62.

Indexed‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (새로운 창 열기)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (새로운 창 열기)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Source‎: Br J Anaesth 2005;94(4):442-4.

Indexed‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (새로운 창 열기)

Management of anemia in patients who decline blood transfusion. (새로운 창 열기)

Shander A, Goodnough LT

Source‎: Am J Hematol 2018;93(9):1183-91.

Indexed‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (새로운 창 열기)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (새로운 창 열기)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Source‎: Arch Surg 2012;147(3):251-5.

Indexed‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (새로운 창 열기)

Intravenous iron following cardiac surgery does not increase the infection rate. (새로운 창 열기)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Source‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Indexed‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (새로운 창 열기)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (새로운 창 열기)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Source‎: Crit Care 2015;19:49.

Indexed‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (새로운 창 열기)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (새로운 창 열기)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Source‎: Crit Care Med 2024;52(4):618-25.

Indexed‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (새로운 창 열기)